91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Oligonucleotides Market Insights, Forecast to 2030

Global Oligonucleotides Market Insights, Forecast to 2030

Publication ID: 
PB507247182
Publication Date: 
July 22, 2024
Pages: 
116
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 4,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Healthcare [2]
Pharma & Healthcare [3]
Description: 

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Market Analysis and Insights: Global Oligonucleotides Market
The global Oligonucleotides market is projected to grow from US$ 1391.4 million in 2024 to US$ 2478.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
Report Covers:
This report presents an overview of global market for Oligonucleotides market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oligonucleotides, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oligonucleotides, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oligonucleotides revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oligonucleotides market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oligonucleotides revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Segment by Type
DNA Oligos
RNA Oligos
Segment by Application
Pharmaceutical
Research
Diagnostic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oligonucleotides in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotides companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligonucleotides revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotides Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 DNA Oligos
1.2.3 RNA Oligos
1.3 Market by Application
1.3.1 Global Oligonucleotides Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Research
1.3.4 Diagnostic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotides Market Perspective (2019-2030)
2.2 Global Oligonucleotides Growth Trends by Region
2.2.1 Oligonucleotides Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oligonucleotides Historic Market Size by Region (2019-2024)
2.2.3 Oligonucleotides Forecasted Market Size by Region (2025-2030)
2.3 Oligonucleotides Market Dynamics
2.3.1 Oligonucleotides Industry Trends
2.3.2 Oligonucleotides Market Drivers
2.3.3 Oligonucleotides Market Challenges
2.3.4 Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oligonucleotides by Players
3.1.1 Global Oligonucleotides Revenue by Players (2019-2024)
3.1.2 Global Oligonucleotides Revenue Market Share by Players (2019-2024)
3.2 Global Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oligonucleotides, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Oligonucleotides Market Concentration Ratio
3.4.1 Global Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotides Revenue in 2023
3.5 Global Key Players of Oligonucleotides Head office and Area Served
3.6 Global Key Players of Oligonucleotides, Product and Application
3.7 Global Key Players of Oligonucleotides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotides Breakdown Data by Type
4.1 Global Oligonucleotides Historic Market Size by Type (2019-2024)
4.2 Global Oligonucleotides Forecasted Market Size by Type (2025-2030)
5 Oligonucleotides Breakdown Data by Application
5.1 Global Oligonucleotides Historic Market Size by Application (2019-2024)
5.2 Global Oligonucleotides Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oligonucleotides Market Size (2019-2030)
6.2 North America Oligonucleotides Market Size by Type
6.2.1 North America Oligonucleotides Market Size by Type (2019-2024)
6.2.2 North America Oligonucleotides Market Size by Type (2025-2030)
6.2.3 North America Oligonucleotides Market Share by Type (2019-2030)
6.3 North America Oligonucleotides Market Size by Application
6.3.1 North America Oligonucleotides Market Size by Application (2019-2024)
6.3.2 North America Oligonucleotides Market Size by Application (2025-2030)
6.3.3 North America Oligonucleotides Market Share by Application (2019-2030)
6.4 North America Oligonucleotides Market Size by Country
6.4.1 North America Oligonucleotides Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Oligonucleotides Market Size by Country (2019-2024)
6.4.3 North America Oligonucleotides Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oligonucleotides Market Size (2019-2030)
7.2 Europe Oligonucleotides Market Size by Type
7.2.1 Europe Oligonucleotides Market Size by Type (2019-2024)
7.2.2 Europe Oligonucleotides Market Size by Type (2025-2030)
7.2.3 Europe Oligonucleotides Market Share by Type (2019-2030)
7.3 Europe Oligonucleotides Market Size by Application
7.3.1 Europe Oligonucleotides Market Size by Application (2019-2024)
7.3.2 Europe Oligonucleotides Market Size by Application (2025-2030)
7.3.3 Europe Oligonucleotides Market Share by Application (2019-2030)
7.4 Europe Oligonucleotides Market Size by Country
7.4.1 Europe Oligonucleotides Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Oligonucleotides Market Size by Country (2019-2024)
7.4.3 Europe Oligonucleotides Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oligonucleotides Market Size (2019-2030)
8.2 China Oligonucleotides Market Size by Type
8.2.1 China Oligonucleotides Market Size by Type (2019-2024)
8.2.2 China Oligonucleotides Market Size by Type (2025-2030)
8.2.3 China Oligonucleotides Market Share by Type (2019-2030)
8.3 China Oligonucleotides Market Size by Application
8.3.1 China Oligonucleotides Market Size by Application (2019-2024)
8.3.2 China Oligonucleotides Market Size by Application (2025-2030)
8.3.3 China Oligonucleotides Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Oligonucleotides Market Size (2019-2030)
9.2 Asia Oligonucleotides Market Size by Type
9.2.1 Asia Oligonucleotides Market Size by Type (2019-2024)
9.2.2 Asia Oligonucleotides Market Size by Type (2025-2030)
9.2.3 Asia Oligonucleotides Market Share by Type (2019-2030)
9.3 Asia Oligonucleotides Market Size by Application
9.3.1 Asia Oligonucleotides Market Size by Application (2019-2024)
9.3.2 Asia Oligonucleotides Market Size by Application (2025-2030)
9.3.3 Asia Oligonucleotides Market Share by Application (2019-2030)
9.4 Asia Oligonucleotides Market Size by Region
9.4.1 Asia Oligonucleotides Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Oligonucleotides Market Size by Region (2019-2024)
9.4.3 Asia Oligonucleotides Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oligonucleotides Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Oligonucleotides Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oligonucleotides Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Oligonucleotides Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Oligonucleotides Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Oligonucleotides Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oligonucleotides Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Oligonucleotides Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Oligonucleotides Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Oligonucleotides Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oligonucleotides Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Oligonucleotides Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Oligonucleotides Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Details
11.1.2 Integrated DNA Technologies Business Overview
11.1.3 Integrated DNA Technologies Oligonucleotides Introduction
11.1.4 Integrated DNA Technologies Revenue in Oligonucleotides Business (2019-2024)
11.1.5 Integrated DNA Technologies Recent Developments
11.2 Agilent
11.2.1 Agilent Company Details
11.2.2 Agilent Business Overview
11.2.3 Agilent Oligonucleotides Introduction
11.2.4 Agilent Revenue in Oligonucleotides Business (2019-2024)
11.2.5 Agilent Recent Developments
11.3 Sigma-aldrich
11.3.1 Sigma-aldrich Company Details
11.3.2 Sigma-aldrich Business Overview
11.3.3 Sigma-aldrich Oligonucleotides Introduction
11.3.4 Sigma-aldrich Revenue in Oligonucleotides Business (2019-2024)
11.3.5 Sigma-aldrich Recent Developments
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Company Details
11.4.2 Eurofins Genomics Business Overview
11.4.3 Eurofins Genomics Oligonucleotides Introduction
11.4.4 Eurofins Genomics Revenue in Oligonucleotides Business (2019-2024)
11.4.5 Eurofins Genomics Recent Developments
11.5 L.G.C Biosearch Technologies
11.5.1 L.G.C Biosearch Technologies Company Details
11.5.2 L.G.C Biosearch Technologies Business Overview
11.5.3 L.G.C Biosearch Technologies Oligonucleotides Introduction
11.5.4 L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2019-2024)
11.5.5 L.G.C Biosearch Technologies Recent Developments
11.6 Eurogentec S.A
11.6.1 Eurogentec S.A Company Details
11.6.2 Eurogentec S.A Business Overview
11.6.3 Eurogentec S.A Oligonucleotides Introduction
11.6.4 Eurogentec S.A Revenue in Oligonucleotides Business (2019-2024)
11.6.5 Eurogentec S.A Recent Developments
11.7 Nitto Denko Avecia Inc
11.7.1 Nitto Denko Avecia Inc Company Details
11.7.2 Nitto Denko Avecia Inc Business Overview
11.7.3 Nitto Denko Avecia Inc Oligonucleotides Introduction
11.7.4 Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2019-2024)
11.7.5 Nitto Denko Avecia Inc Recent Developments
11.8 GenScript
11.8.1 GenScript Company Details
11.8.2 GenScript Business Overview
11.8.3 GenScript Oligonucleotides Introduction
11.8.4 GenScript Revenue in Oligonucleotides Business (2019-2024)
11.8.5 GenScript Recent Developments
11.9 BBI Life Sciences
11.9.1 BBI Life Sciences Company Details
11.9.2 BBI Life Sciences Business Overview
11.9.3 BBI Life Sciences Oligonucleotides Introduction
11.9.4 BBI Life Sciences Revenue in Oligonucleotides Business (2019-2024)
11.9.5 BBI Life Sciences Recent Developments
11.10 GeneDesign
11.10.1 GeneDesign Company Details
11.10.2 GeneDesign Business Overview
11.10.3 GeneDesign Oligonucleotides Introduction
11.10.4 GeneDesign Revenue in Oligonucleotides Business (2019-2024)
11.10.5 GeneDesign Recent Developments
11.11 TriLink BioTechnologies
11.11.1 TriLink BioTechnologies Company Details
11.11.2 TriLink BioTechnologies Business Overview
11.11.3 TriLink BioTechnologies Oligonucleotides Introduction
11.11.4 TriLink BioTechnologies Revenue in Oligonucleotides Business (2019-2024)
11.11.5 TriLink BioTechnologies Recent Developments
11.12 SGS DNA
11.12.1 SGS DNA Company Details
11.12.2 SGS DNA Business Overview
11.12.3 SGS DNA Oligonucleotides Introduction
11.12.4 SGS DNA Revenue in Oligonucleotides Business (2019-2024)
11.12.5 SGS DNA Recent Developments
11.13 LC Sciences
11.13.1 LC Sciences Company Details
11.13.2 LC Sciences Business Overview
11.13.3 LC Sciences Oligonucleotides Introduction
11.13.4 LC Sciences Revenue in Oligonucleotides Business (2019-2024)
11.13.5 LC Sciences Recent Developments
11.14 Twist Bioscience
11.14.1 Twist Bioscience Company Details
11.14.2 Twist Bioscience Business Overview
11.14.3 Twist Bioscience Oligonucleotides Introduction
11.14.4 Twist Bioscience Revenue in Oligonucleotides Business (2019-2024)
11.14.5 Twist Bioscience Recent Developments
11.15 Creative Biogene
11.15.1 Creative Biogene Company Details
11.15.2 Creative Biogene Business Overview
11.15.3 Creative Biogene Oligonucleotides Introduction
11.15.4 Creative Biogene Revenue in Oligonucleotides Business (2019-2024)
11.15.5 Creative Biogene Recent Developments
11.16 General Biosystems
11.16.1 General Biosystems Company Details
11.16.2 General Biosystems Business Overview
11.16.3 General Biosystems Oligonucleotides Introduction
11.16.4 General Biosystems Revenue in Oligonucleotides Business (2019-2024)
11.16.5 General Biosystems Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned: 

Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-oligonucleotides-market-insights-forecast-2030

Links
[1] /countries/global[2] /healthcare[3] /pharma-healthcare